Blood
Slide deck, chapter 2235 slidesChapter outline and sourcesPractice questions
-
22.1 Whole blood, plasma and the formed elements
- A centrifuged tube layers into packed red cells at the bottom, a thin buffy coat of WBCs and platelets, and straw-colored plasma on top.
- Whole blood is about 45 percent formed elements and 55 percent plasma; red cells are over 99 percent of the formed elements.
- Hematocrit is the red cell share of total volume: about 40 to 55 percent in men and 36 to 48 percent in women (labs vary), since testosterone raises EPO.
- Low hematocrit means anemia; high means polycythemia or a shrunken plasma volume from dehydration, and either way viscosity and flow resistance shift.
Outcome
- 1Describe the components of whole blood, plasma and formed elements and calculate hematocrit and plasma fraction from a centrifuged tube.
-
22.1 Working a centrifuged tube
- Hematocrit equals the packed-cell column height divided by the full column height, times 100.
- A 10 cm column with 4.5 cm of packed cells has a hematocrit of 45 percent; plasma is the remaining 55 percent, because the buffy coat is negligible.
- Plasma volume equals total blood volume times (1 minus hematocrit): 5 L of blood at hematocrit 45 percent holds about 2.75 L of plasma.
- Packing is imperfect: 3 to 4 percent of the plasma stays trapped among the red cells, so the true hematocrit is about 96 percent of the measured one.
Outcome
- 1Describe the components of whole blood, plasma and formed elements and calculate hematocrit and plasma fraction from a centrifuged tube.
-
22.1 Plasma proteins and oncotic pressure
- Plasma is about 91.5 percent water; proteins are about 7 percent by weight and the liver makes most of them.
- By share of protein: albumin 54 percent, globulins 38 percent, fibrinogen 7 percent. Gamma globulins are antibodies from plasma cells; alpha and beta globulins carry iron, lipids and vitamins.
- Fibrinogen is factor I and becomes fibrin in clotting; serum is plasma after clotting, so it lacks fibrinogen and other consumed clotting factors.
- Oncotic pressure is about 25 mm Hg (Guyton gives 28), roughly 80 percent from albumin: osmotic pressure follows molecule number, and albumin is small (about 69,000) and plentiful.
- Low albumin (liver disease, nephrotic syndrome, malnutrition) lowers oncotic pressure, so filtration exceeds reabsorption and edema forms.
Outcome
- 2Classify plasma proteins by origin and function, including albumin, globulins, fibrinogen and their contribution to oncotic pressure.
-
22.1 Reference properties of blood
- pH is 7.35 to 7.45, slightly alkaline; temperature is about 38 C, roughly 1 C above oral temperature.
- Volume is about 5 L in an adult, 7 to 8 percent of body weight; the textbook rule is about 75 mL/kg in men and 65 mL/kg in women, so size and sex matter.
- Viscosity is about 3 times that of water, set mostly by red cell number plus plasma proteins; in polycythemia vera it can reach about 10 times.
- Plasma osmolality is about 275-295 mOsm/kg of water (older texts round to 300); ADH, aldosterone and ANP regulate water excretion to hold volume and osmolality steady.
Outcome
- 3Give the reference values for blood volume, pH, viscosity and osmolality and explain what changes each.
-
22.1 The hematopoietic hierarchy
- Pluripotent stem cells make up only 0.05 to 0.1 percent of red marrow cells; they self-renew and split into myeloid and lymphoid stem cells.
- Myeloid line gives red cells, platelets, monocytes, neutrophils, eosinophils and basophils; lymphoid line gives B, T and NK cells and finishes maturing in lymphatic tissue.
- Committed progenitors (CFU-E, CFU-Meg, CFU-GM) cannot self-renew and look like lymphocytes; recognizable precursors (blasts) follow.
- Erythroid precursors eject the nucleus to become reticulocytes, megakaryocytes fragment into platelets, and granulocytes and monocytes share a progenitor.
Outcome
- 4Trace hematopoiesis from the hematopoietic stem cell through myeloid and lymphoid progenitors to each mature cell line.
-
22.1 Where blood forms and what drives it
- Before birth: yolk sac first, then liver from about week 7 (spleen and lymphoid organs also help). Marrow is colonized near week 11 and leads after about week 20, the main site for life.
- Newborn marrow is all red; with age the shaft marrow turns to fatty yellow marrow, which can revert to red in severe blood loss.
- Adult red marrow lies mainly in the axial skeleton, pectoral and pelvic girdles and the proximal humerus and femur.
- EPO (kidney) drives red cells and thrombopoietin (liver) drives platelets; G-CSF and GM-CSF stimulate white cells, IL-5 eosinophils and IL-7 lymphoid cells.
- Recombinant EPO treats anemia of kidney failure; CSFs and thrombopoietin speed recovery after chemotherapy and marrow transplant.
Outcome
- 5Name the sites of blood cell formation across fetal life, childhood and adulthood and the cytokines that drive each lineage.
-
22.1 Reading bone marrow
- Red marrow is cellular, with islands of developing cells beside leaky sinusoids; yellow marrow is mostly adipocytes.
- Megakaryocytes are huge multilobed cells beside sinusoids; platelets bud off into the sinusoid lumen.
- Erythroid cells shrink as they mature, cytoplasm shifts from deep blue to pink as hemoglobin accumulates, and the nucleus condenses and is ejected.
- Granulocyte precursors go from myeloblast to myelocyte and metamyelocyte (nucleus indents, specific granules appear) to band and segmented cell.
- Aspirate samples cells and core biopsy shows architecture, usually from the iliac crest.
Outcome
- 6Recognize bone marrow cell lineages and red versus yellow marrow on marrow smears and sections.
-
22.2 Red cell shape, membrane and metabolism
- A mature RBC is a biconcave disc about 7 to 8 micrometers across with no nucleus; the thin shape puts hemoglobin close to the membrane for fast gas diffusion.
- Extra membrane for the volume lets the cell fold through narrow capillaries without stretching and rupturing.
- Spectrin, ankyrin, band 3 and protein 4.1 anchor the membrane to the cytoskeleton; defects cause hereditary spherocytosis and elliptocytosis.
- No mitochondria: glycolysis makes ATP; the pentose phosphate pathway makes NADPH, so G6PD deficiency gives oxidant hemolysis with Heinz bodies.
- Lifespan is about 120 days; counts are about 4.6 to 6.2 million per microliter in men and 4.2 to 5.4 million in women.
Outcome
- 7Describe the biconcave RBC shape, membrane cytoskeleton and anucleate metabolism and explain how they support gas transport and deformability.
-
22.2 Hemoglobin and the oxygen curve
- HbA is a tetramer of two alpha and two beta chains; each carries a heme with one Fe2+ that binds one O2.
- Adult hemoglobin is over 95 percent HbA, 2 to 3 percent HbA2 (alpha2 delta2) and about 1 to 2 percent HbF (alpha2 gamma2).
- Binding is cooperative: each bound O2 shifts the molecule from the tense to the relaxed state, making further binding easier and giving a sigmoid curve.
- Right shift (easier unloading) with higher PCO2, H+, temperature and 2,3-BPG, the Bohr effect; left shift with the opposite, with CO and with HbF.
- HbF binds 2,3-BPG less strongly, so it takes up more O2 at low PO2, favoring transfer from maternal blood across the placenta.
Outcome
- 8Explain the structure of adult, fetal and variant hemoglobin, including heme, globin chains and the cooperative binding that shapes the oxyhemoglobin dissociation curve.
-
22.2 Hemoglobin variants and heme synthesis
- Sickle cell disease: Glu6Val in beta globin lets deoxygenated HbS polymerize, causing sickling, vaso-occlusion and hemolysis; trait protects against malaria.
- Thalassemias reduce alpha or beta chain output; unpaired chains damage cells and cause microcytic anemia, and beta-thalassemia raises HbA2 and HbF.
- Methemoglobin contains Fe3+ and cannot bind O2.
- Heme synthesis starts with ALA synthase, which needs vitamin B6; lead inhibits ALA dehydratase and ferrochelatase.
Outcome
- 8Explain the structure of adult, fetal and variant hemoglobin, including heme, globin chains and the cooperative binding that shapes the oxyhemoglobin dissociation curve.
-
22.2 Erythropoietin and oxygen sensing
- Peritubular interstitial cells of the renal cortex make EPO when O2 delivery falls; the liver is the main source in the fetus and newborn.
- In normoxia prolyl hydroxylase marks HIF-alpha for VHL-mediated destruction; in hypoxia HIF-alpha is stabilized and raises EPO gene transcription.
- EPO acts on CFU-E and proerythroblasts through its receptor and JAK2-STAT5, preventing apoptosis and speeding maturation.
- Altitude and anemia raise EPO; in kidney failure EPO stays low despite anemia, so hematocrit falls and recombinant EPO corrects it.
- Polycythemia vera has JAK2 V617F with low EPO, while EPO doping raises hematocrit and viscosity.
Outcome
- 9Describe regulation of erythropoietin by renal hypoxia through HIF and predict its response to altitude, anemia and renal failure.
-
22.2 Iron: absorption, transport, storage, recycling
- Most body iron sits in hemoglobin; heme iron is absorbed better than non-heme iron, and total iron is regulated mainly by changing the rate of absorption.
- Duodenal enterocytes reduce Fe3+ to Fe2+, take it up through DMT1 and export it through ferroportin.
- In plasma, iron travels on transferrin; stores are ferritin (and hemosiderin) in liver, muscle and macrophages; erythroblasts take iron up by transferrin receptor endocytosis.
- Macrophages recycle iron from aged red cells back onto transferrin.
- Hepcidin from the liver blocks ferroportin: it rises with inflammation (anemia of chronic disease) and falls in iron deficiency and hemochromatosis.
Outcome
- 10Trace dietary iron absorption, transport, storage and recycling, including hepcidin.
-
22.2 Vitamin B12 and folate
- Both are needed to make thymidylate for DNA; without them DNA replication stalls while RNA and hemoglobin synthesis continue, so precursors grow large (megaloblastic anemia).
- B12 needs intrinsic factor from gastric parietal cells and is absorbed in the terminal ileum; loss of intrinsic factor (pernicious anemia, gastrectomy) causes deficiency.
- Folate is absorbed in the jejunum and its stores last months; B12 stores last years.
- A smear shows macro-ovalocytes and hypersegmented neutrophils; B12 deficiency also damages the spinal cord, and a raised methylmalonic acid separates it from folate deficiency.
Outcome
- 11Explain the roles of vitamin B12 and folate in DNA synthesis and the absorption of B12 requiring intrinsic factor.
-
22.2 Classifying anemia
- First by size using MCV: microcytic under 80 fL, normocytic about 80 to 100 fL, macrocytic over 100 fL; then by mechanism: low production, high destruction, or blood loss.
- Microcytic: iron deficiency, thalassemia, chronic disease, sideroblastic. Normocytic: acute blood loss, hemolysis, renal disease. Macrocytic: B12 or folate deficiency, liver disease, alcohol.
- The reticulocyte count separates underproduction (low) from blood loss or hemolysis (high).
- Iron deficiency: low ferritin, high TIBC, small pale cells. Chronic disease: high ferritin with low iron and low TIBC. Overload: high ferritin and high transferrin saturation.
- Aplastic anemia is pancytopenia with a hypocellular marrow; renal anemia reflects low EPO.
Outcome
- 12Classify anemias by MCV and mechanism and interpret hemoglobin, MCV, reticulocyte count and iron studies.
-
22.2 Red cell destruction and jaundice
- Aged, fragile red cells are removed by macrophages of spleen and liver; globin amino acids and iron are recycled.
- Heme becomes biliverdin, then unconjugated bilirubin bound to albumin; the liver conjugates it into bile, and gut bacteria make urobilinogen.
- Prehepatic jaundice (hemolysis): unconjugated bilirubin, LDH and reticulocytes rise and haptoglobin falls.
- Hepatic jaundice reflects failed uptake, conjugation or cell damage; post-hepatic (obstructive) jaundice backs up conjugated bilirubin, giving dark urine and pale stools.
- Newborn jaundice follows immature conjugation; very high unconjugated bilirubin can enter the brain (kernicterus).
Outcome
- 13Trace RBC senescence and heme catabolism to unconjugated bilirubin and describe jaundice types.
-
22.3 Granulocytes on a Wright-stained smear
- Neutrophil: 10 to 12 micrometers, nucleus with 2 to 5 lobes joined by thin strands, fine pale lilac granules; a band has an unsegmented U-shaped nucleus.
- Eosinophil: usually two lobes, with large uniform red-orange granules that do not hide the nucleus.
- Basophil: slightly smaller (8 to 10 micrometers) with variable dark blue-purple granules that often obscure the two-lobed nucleus.
- Separate by granule color, then lobes; females may show a drumstick (Barr body) on neutrophils; over five lobes suggests megaloblastic anemia.
Outcome
- 14Identify the five leukocyte types on a Wright-stained smear using size, nuclear shape, chromatin and granule color.
-
22.3 Agranulocytes on a smear
- Small lymphocyte: 6 to 9 micrometers, dark round nucleus filling most of the cell, thin rim of sky-blue cytoplasm; larger lymphocytes (10 to 14) have more cytoplasm and include NK cells.
- Monocyte: the largest leukocyte (12 to 20 micrometers) with an indented or horseshoe nucleus and abundant gray-blue cytoplasm.
- Monocyte versus band: the monocyte is larger, with lacy chromatin and gray-blue cytoplasm; the band has a smooth, thick U-shaped nucleus and pale granules.
- Reactive lymphocytes in viral illness are larger, with more abundant cytoplasm.
Outcome
- 14Identify the five leukocyte types on a Wright-stained smear using size, nuclear shape, chromatin and granule color.
-
22.3 Reference counts and common shifts
- Total WBC is about 4500 to 11,000 per microliter; above that range is leukocytosis and below it is leukopenia (labs vary slightly).
- Differential: neutrophils 50 to 70, lymphocytes 20 to 30, monocytes 2 to 8, eosinophils 2 to 4, basophils under 1 percent.
- Absolute count equals percentage times total WBC: 60 percent neutrophils at 8000 per microliter is 4800 per microliter.
- Neutrophilia: bacterial infection, stress, burns. Eosinophilia: allergy, parasites. Lymphocytosis: viral infection. Monocytosis: chronic infection such as tuberculosis.
Outcome
- 15Give the reference differential and absolute counts for each leukocyte type and state the causes of common shifts.
-
22.3 Leukocyte responses to infection and allergy
- Neutrophils arrive first: selectins and integrins mediate emigration, chemotaxis guides them, and lysozyme, defensins and oxidants kill the microbe.
- The respiratory burst depends on NADPH oxidase; its absence causes chronic granulomatous disease.
- Monocytes arrive later in greater numbers, become macrophages and clear debris and microbes.
- Eosinophils blunt allergic inflammation, clear antigen-antibody complexes and attack parasitic worms.
- Basophils and mast cells release histamine and heparin and intensify inflammation and hypersensitivity.
Outcome
- 16Describe the neutrophil, monocyte, eosinophil and basophil responses to infection and allergic disease at overview level.
-
22.3 Megakaryocytes and platelets
- Thrombopoietin, made in liver and kidney, pushes myeloid cells to megakaryoblasts and megakaryocytes, which fragment into 2000 to 3000 platelets each.
- A platelet is a 2 to 4 micrometer anucleate fragment; count is about 150,000 to 400,000 per microliter, about one third is held in the spleen, and lifespan is 7 to 10 days.
- Membrane glycoproteins matter: GPIb binds von Willebrand factor and GPIIb/IIIa binds fibrinogen.
- Alpha granules hold vWF, fibrinogen and PDGF; dense granules hold ADP, ATP, serotonin and Ca2+.
Outcome
- 17Trace platelet formation from megakaryocyte under thrombopoietin and describe the platelet granules and membrane features.
-
22.3 Interpreting abnormal counts
- Leukocytosis is a normal response to infection, stress, exercise and surgery; leukopenia follows radiation, shock, chemotherapy or marrow failure.
- Left shift means more bands and immature forms, a marrow response to bacterial infection; hypersegmentation is the opposite pattern.
- Thrombocytopenia causes petechiae and mucosal bleeding: minor bleeding after trauma at 20,000 to 50,000 per microliter, spontaneous bleeding at 20,000 or less, severe at 5000 or less.
- Causes include ITP, TTP, DIC, heparin-induced thrombocytopenia and marrow failure; thrombocytosis raises the risk of thrombosis.
- Neutropenia is a neutrophil count under about 1500 per microliter: mild 1000 to 1500, moderate 500 to 1000, severe under 500, when infection risk climbs and fever may be the only sign.
Outcome
- 18Interpret leukocytosis, leukopenia, thrombocytopenia and thrombocytosis and the left shift.
-
22.4 From injury to a stable plug
- Vascular spasm: smooth muscle contracts in response to endothelin and pain reflexes, lasting up to about 30 minutes.
- Adhesion: exposed collagen binds von Willebrand factor, which captures platelets through GPIb.
- Activation: platelets change shape, release ADP and serotonin and make thromboxane A2 (COX-1, blocked by aspirin).
- Aggregation: GPIIb/IIIa binds fibrinogen bridges between platelets; clopidogrel blocks the ADP receptor P2Y12.
- Bernard-Soulier is GPIb deficiency and Glanzmann is GPIIb/IIIa deficiency; platelet defects give mucocutaneous bleeding, factor defects deep bleeding.
Outcome
- 19Sequence vascular spasm, platelet plug formation (adhesion, activation, aggregation) and coagulation in a bleeding injury.
-
22.4 The coagulation cascade
- Extrinsic: tissue factor (III) with VIIa and Ca2+ activates X within seconds; PT measures this limb.
- Intrinsic: contact activation of XII, then XI, then IX; IXa with VIIIa on a phospholipid surface activates X, taking minutes; aPTT measures this limb.
- Common: Xa with Va, Ca2+ and phospholipid (prothrombinase) converts prothrombin to thrombin, which converts fibrinogen to fibrin.
- Thrombin also activates V, VIII, XI and XIII; XIIIa cross-links fibrin to stabilize the clot.
Outcome
- 20Diagram the intrinsic, extrinsic and common coagulation pathways with factors, cofactors, calcium and phospholipid surface.
-
22.4 Cell-based model of coagulation
- Initiation: tissue factor on cells outside the vessel binds VIIa and activates X, producing a small amount of thrombin.
- Amplification: that thrombin activates platelets and cofactors V and VIII, and XI, on the platelet surface.
- Propagation: tenase (IXa with VIIIa) and prothrombinase (Xa with Va) assemble on platelets, producing a large thrombin burst and fibrin.
- Tissue factor is the physiologic trigger; this explains why XII deficiency does not cause bleeding while VIII or IX deficiency does.
Outcome
- 21Explain the cell-based model of coagulation as initiation, amplification and propagation on cell surfaces.
-
22.4 Reading PT, aPTT and related tests
- PT adds tissue factor and Ca2+ and reflects VII, X, V, II and I; normal is about 11 to 13.5 seconds (INR 0.8 to 1.1), and the INR standardizes it across labs.
- aPTT adds a contact activator, phospholipid and Ca2+ and reflects XII, XI, IX, VIII and the common pathway; normal is about 25 to 35 seconds, and it monitors unfractionated heparin.
- Long aPTT with normal PT: factor VIII, IX or XI deficiency or heparin. Long PT with normal aPTT: factor VII deficiency or early warfarin.
- A mixing study corrects a factor deficiency but not an inhibitor such as lupus anticoagulant.
- Thrombin time tests fibrinogen conversion and is long with heparin or low fibrinogen; platelet count and fibrinogen cover the other limbs.
Outcome
- 22Interpret PT/INR, aPTT, thrombin time, platelet count and fibrinogen results and predict which factors or drugs they reflect.
-
22.4 Vitamin K, thrombin and fibrin
- Vitamin K gamma-carboxylates glutamate on II, VII, IX, X and proteins C and S, which lets them bind Ca2+ and phospholipid.
- Warfarin blocks vitamin K epoxide reductase; factor VII has the shortest half-life so PT lengthens first, and early protein C loss can cause skin necrosis.
- Vitamin K comes from diet and gut bacteria; deficiency occurs in fat malabsorption and in newborns.
- Thrombin makes fibrin, activates V, VIII, XI, XIII and platelets, and XIIIa cross-links the fibrin; 85 to 90 percent of thrombin is adsorbed onto forming fibrin.
- On warfarin the INR target is usually 2.0 to 3.0, and 2.5 to 3.5 for some mechanical mitral valves; above the target raises bleeding risk and below it raises clot risk.
Outcome
- 23Describe the roles of vitamin K, thrombin, factor XIII and fibrin in clot formation and the vitamin K dependent factors.
-
22.4 Natural anticoagulants and fibrinolysis
- Antithrombin neutralizes thrombin and Xa; heparin raises its effectiveness a hundredfold to a thousandfold, and low-molecular-weight heparin acts mainly on Xa.
- Thrombomodulin-bound thrombin activates protein C, which with S inactivates Va and VIIIa; factor V Leiden resists this. TFPI blocks VIIa-TF-Xa.
- tPA converts plasminogen on fibrin to plasmin, which digests fibrin into fragments including D-dimer.
- PAI-1 inhibits tPA and alpha-2 antiplasmin inhibits plasmin; tranexamic acid blocks plasminogen binding.
- Alteplase given early in thrombotic stroke helps, but hemorrhage must be excluded first.
Outcome
- 24Explain the anticoagulant and fibrinolytic systems: antithrombin, protein C/S, TFPI, plasmin, tPA and PAI-1.
-
22.4 Bleeding disorders and their steps
- Hemophilia A (factor VIII, about 80 percent of cases) and B (factor IX, about 20 percent) are X-linked; they cause deep bleeding and joint hemorrhage with long aPTT, normal PT and normal platelets.
- von Willebrand disease impairs platelet adhesion, giving mucocutaneous bleeding; it is the commonest inherited bleeding disorder.
- DIC: widespread activation consumes platelets, fibrinogen and factors, giving long PT and aPTT, low platelets and fibrinogen, and raised D-dimer.
- Liver disease lowers synthesis of most factors and prolongs PT; vitamin K deficiency does the same for the dependent factors.
Outcome
- 25Relate hemophilia A and B, von Willebrand disease, DIC, thrombosis and anticoagulant drugs to specific steps of hemostasis.
-
22.4 Thrombosis and where drugs act
- Virchow triad (stasis, endothelial injury, hypercoagulability) drives thrombosis; a thrombus that breaks free is an embolus, so DVT can cause pulmonary embolism.
- Aspirin blocks COX-1 and thromboxane A2; clopidogrel blocks P2Y12; abciximab blocks GPIIb/IIIa.
- Heparin works through antithrombin; warfarin reduces vitamin K dependent factors.
- DOACs inhibit Xa (rivaroxaban, apixaban) or thrombin (dabigatran).
- Heparin-induced thrombocytopenia is paradoxically prothrombotic because anti-PF4/heparin antibodies activate platelets.
Outcome
- 25Relate hemophilia A and B, von Willebrand disease, DIC, thrombosis and anticoagulant drugs to specific steps of hemostasis.
-
22.5 ABO antigens and antibodies
- A and B are carbohydrate antigens built on the H antigen: the A enzyme adds N-acetylgalactosamine, the B enzyme adds galactose, and the O enzyme is inactive so only H shows.
- A and B alleles are codominant and O is recessive: AA or AO is type A, BB or BO type B, AB is AB, OO is type O.
- Antibodies to the missing antigen appear within months of birth, driven by A- and B-like antigens in food and gut bacteria; they are mostly IgM.
- Group O has anti-A and anti-B, A has anti-B, B has anti-A, and AB has neither.
- The Bombay phenotype lacks the H antigen, so it types as O yet makes anti-H; that antibody hemolyzes all red cells except Bombay cells, so even group O blood is unsafe.
Outcome
- 26Explain the ABO antigens, their biochemical basis in the H antigen and the naturally occurring antibodies.
-
22.5 Predicting offspring phenotypes
- AO times BO gives AB, AO, BO and OO in equal quarters, so all four groups can arise from one couple.
- Rh D is dominant: D-positive people are DD or Dd and D-negative people are dd; two D-negative parents can only have D-negative children.
- Dd times Dd gives three D-positive for every one D-negative child.
- ABO and Rh assort independently, so multiply: AO Dd times BO Dd gives type O D-negative with probability 1/4 times 1/4, or 1/16.
- In the US about 45 percent of people are group O, 40 percent A, 11 percent B and 4 to 5 percent AB; O positive (about 38 percent) is the commonest single type.
Outcome
- 27Predict the possible offspring phenotypes of an ABO and Rh cross using the genotypes.
-
22.5 Rh antigens versus ABO antibodies
- The Rh system is protein antigens; D is the clinically dominant one, and Rh positive means D is present (over 80 percent of the US population).
- No natural anti-D exists: an Rh-negative person forms it only after exposure, and the response builds over weeks to months.
- Anti-D is IgG and crosses the placenta; natural anti-A and anti-B are mostly IgM, yet ABO mismatch (often group O mother) is a usually mild cause of newborn jaundice.
- ABO mismatch reacts at once because antibodies pre-exist; Rh mismatch needs prior sensitization, so a first transfusion or pregnancy is usually spared.
Outcome
- 28Compare the Rh system antigens with ABO antibodies by immunoglobulin class and clinical significance.
-
22.5 Donor-recipient compatibility and crossmatch
- Red cells: O goes to all, A to A and AB, B to B and AB, AB only to AB; O negative is the emergency donor and AB positive the universal red cell recipient.
- Plasma compatibility is reversed: AB plasma has no anti-A or anti-B and goes to anyone; O plasma suits only group O recipients.
- Type and screen: forward typing (patient cells with anti-A, anti-B, anti-D), reverse typing (patient serum against A and B cells) and an antibody screen.
- Crossmatch mixes donor cells with recipient serum: immediate spin detects ABO incompatibility; an antiglobulin phase detects IgG antibodies. Clumping or hemolysis means incompatible.
- Rh-negative women of child-bearing potential should receive D-negative products.
Outcome
- 29Determine donor-recipient compatibility for red cells and plasma and describe the steps of the crossmatch.
-
22.5 Hemolytic disease of the fetus and newborn
- An Rh-negative mother is sensitized by D-positive fetal cells entering her blood, most often at delivery; without prophylaxis this happens in about 13 to 16 percent of such pregnancies.
- In a later D-positive pregnancy IgG anti-D crosses the placenta and destroys fetal red cells, causing anemia, hydrops and bilirubin accumulation; kernicterus is a risk after birth.
- Prevention: Rh immune globulin at about 28 weeks and within 72 hours after delivery of an Rh-positive baby, and after sensitizing events; a Kleihauer-Betke test or flow cytometry sizes a large bleed.
- Immune globulin was licensed for routine postpartum use in 1968; with antenatal plus postpartum doses, sensitization falls below about 0.2 percent.
Outcome
- 30Explain hemolytic disease of the fetus and newborn and the role of anti-D prophylaxis.
-
22.5 Transfusion reactions and first response
- Acute hemolytic reaction (ABO mismatch): intravascular hemolysis with fever, hypotension, flank pain, hemoglobinuria, kidney injury and possible DIC.
- First steps: stop the transfusion, keep IV access with saline, recheck labels and patient identity, send samples to the blood bank and support blood pressure and urine output.
- Delayed hemolytic reaction occurs days later in a sensitized patient, with extravascular hemolysis and a positive direct antiglobulin (Coombs) test.
- Non-hemolytic: febrile (leukocyte cytokines), allergic or anaphylactic (IgA deficiency), TRALI (donor anti-leukocyte antibodies, lung injury) and TACO (volume overload).
Outcome
- 31Describe the acute and delayed hemolytic and non-hemolytic transfusion reactions and the initial management.